Top 20 Publicly Traded Healthcare Companies by Market Cap in 2025

Cencora, formerly AmerisourceBergen, manages an extensive pharmaceutical and biotech distribution network. It recently expanded its Drug Shortages Mitigation Program and launched Accelerate Pharmacy Solutions to enhance supply chain resiliency and pharmacy efficiency.

Cardinal Health (CAH)

Cardinal Health is a major player in medical product distribution and healthcare logistics. In its 2025’s second quarter report, it showed a 6% increase in operating earnings. It expanded its multi‑specialty care through acquisitions of GI Alliance and Integrated Oncology Network, launched actinium‑225 production and began construction on a new at‑Home Solutions center.

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR)

The company trades on the Saudi Stock Exchange (Tadawul) in Saudi Riyals.

With advanced hospitals and telemedicine services, this Saudi Arabia-based group is working to expand specialized care across the Middle East. The Group recently partnered with NLC Health Ventures to accelerate global health tech innovations, aiming to enhance telemedicine and remote care solutions.

Centene (CNC)

Centene, a leader in government‑sponsored healthcare plans, delivered 2024 adjusted EPS of $7.17 and 19% premium revenue growth to $38.6 billion, serving 5.5 million members. Centene raised 2025 guidance — expecting about $42 billion in premium revenue and at least $24.50 adjusted EPS — is supported by new contracts and community grants, including a $550K grant for a mobile clinic in Hawai’i and $528K in grants supporting Illinois community health.

Fresenius (FRE.DE)

The company trades on the Frankfurt Stock Exchange in Euros.

Fresenius provides hospital operations, infusion therapies and more. Its home dialysis programs allow patients with chronic kidney disease to receive treatments outside of traditional clinical settings. Fresenius plans to share its fourth quarter and full-year 2024 earnings on February 25, 2025.

Pro Medicus (PME.AX)

The company trades on the Australian Stock Exchange in AUD.

A leading health imaging provider, Pro Medicus reported half‑year revenue of $97.2 million and net profit of $51.7 million with EBIT margins at 72%. It secured record contracts totaling over $365M and key renewals, while Duke and NYU Langone upgraded to Visage 7 Open Archive as they transitioned to Cloud — reflecting long‑term confidence in its modular platform.

AIER Eye Hospital (300015.SZ)

The company trades on the Shenzhen Stock Exchange in Chinese Yuan (RMB).

Specializing in ophthalmology, AIER Eye Hospital operates a network of eye clinics across China using laser-based surgeries and tele-ophthalmology to serve rural regions. Its initiatives are addressing the growing demand for vision correction among an aging population.

Baxter (BAX)

Baxter, a global leader in specialty injectables, launched five new US injectable products in 2024 —bringing its total to 10 launches — to enhance patient safety and streamline medication preparation. Its innovative portfolio addresses critical needs in kidney care, oncology and surgical care.

Molina Healthcare (MOH)

Molina Healthcare focuses on individuals enrolled in government-sponsored plans. Molina reported solid 2024 results with adjusted EPS of $22.65 and 19% growth in premium revenue to $38.6 billion, serving 5.5 million members. Its 2025 outlook expects premium revenue of about $42 billion and at least $24.50 adjusted EPS, driven by new contracts and operational improvements.

IHH Healthcare (Q0F.SI)

The company trades on Bursa Malaysia in Malaysian Ringgit.

IHH Healthcare operates hospitals across Asia, the Middle East and Europe, with centers of excellence in cardiology and oncology. It earned a spot on the FTSE4Good Index Series, highlighting its commitment to sustainable, high‑quality care and robust ESG practices.

Fresenius Medical Care (FMS)

Fresenius Medical Care concentrates on dialysis and related treatments. It personalizes patient care by integrating nutritional guidance with nephrology services, aiming to reduce hospitalizations. This comprehensive approach is designed to keep kidney disease patients healthier and more active.

DaVita (DVA)

DaVita, a major player in kidney care, operates dialysis centers across the US and pilots at‑home treatments and tele‑dialysis solutions to overcome patient travel barriers. Celebrating its 25th anniversary in 2025, it remains committed to enhancing patient outcomes through innovative care.

Doximity (DOCS)

Doximity, the leading digital platform for US physicians, recorded a third quarter of fiscal 2025 revenue of $168.6 million — a 25% increase compared to the same period the prior year — with net income up 57% and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) growing 39%. Record telehealth engagement and a fourth consecutive Best in KLAS award highlight its innovative, secure virtual care solutions.

From improving access in remote communities to refining complex surgical procedures, these 20 leading publicly traded healthcare companies are not only growing in size, but also tackling critical problems by providing practical solutions.